Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
PTEN Genetic Test: MedlinePlus Lab Test Information

PTEN Genetic Test: MedlinePlus Lab Test Information

What is a PTEN genetic test?

A PTEN genetic test looks for a change, known as a mutation, in a gene called PTEN. Genes are the basic units of heredity passed down from your mother and father.

The PTEN gene helps stop the growth of tumors. It’s known as a tumor suppressor. A tumor suppressor gene is like the brakes on a car. It puts the “brakes” on cells, so they don’t divide too quickly. If you have a PTEN genetic mutation, it can cause the growth of noncancerous tumors called hamartomas. Hamartomas can show up throughout the body. The mutation can also lead to the development of cancerous tumors.

A PTEN genetic mutation can be inherited from your parents, or acquired later in life from the environment or from a mistake that happens in your body during cell division.

An inherited PTEN mutation can cause a variety of health disorders. Some of these can start at infancy or early childhood. Others show up in adulthood. These disorders are often grouped together and called PTEN hamartoma syndrome (PTHS) and include:

  • Cowden syndrome, a disorder that causes the growth of many hamartomas and increases the risk of several types of cancer, including cancers of the breast, uterus, thyroid, and colon. People with Cowden syndrome often have a larger than normal sized head (macrocephaly), developmental delays, and/or autism.
  • Bannayan-Riley-Ruvalcaba syndrome also causes hamartomas and macrocephaly. In addition, people with this syndrome may have learning disabilities and/or autism. Males with the disorder often have dark freckles on the penis.
  • Proteus or Proteus-like syndrome can cause an overgrowth of bones, skin, and other tissues, as well as hamartomas and macrocephaly.

Acquired (also known as somatic) PTEN genetic mutations are one of the commonly found mutations in human cancer. These mutations have been found in many different types of cancer, including prostate cancer, uterine cancer, and some types of brain tumors.

Other names: PTEN gene, full gene analysis; PTEN sequencing and deletion/duplication

What is it used for?

The test is used to look for a PTEN genetic mutation. It is not a routine test. It is usually given to people based on family history, symptoms, or previous diagnosis of cancer, especially cancer of the breast, thyroid, or uterus.

Why do I need a PTEN genetic test?

You or your child may need a PTEN genetic test if you have a family history of a PTEN genetic mutation and/or one or more of the following conditions or symptoms:

  • Multiple hamartomas, especially in the gastrointestinal area
  • Macrocephaly (larger than normal sized head)
  • Developmental delays
  • Autism
  • Dark freckling of the penis in males
  • Breast cancer
  • Thyroid cancer
  • Uterine cancer in females

If you’ve been diagnosed with cancer and don’t have a family history of the disease, your health care provider may order this test to see if PTEN genetic mutation may be causing your cancer. Knowing whether you have the mutation can help your provider predict how your disease will develop and guide your treatment.

What happens during a PTEN genetic test?

A PTEN test is usually a blood test. During a blood test, a health care professional will take a blood sample from a vein in your arm, using a small needle. After the needle is inserted, a small amount of blood will be collected into a test tube or vial. You may feel a little sting when the needle goes in or out. This usually takes less than five minutes.

Will I need to do anything to prepare for the test?

You usually don’t need any special preparations for a PTEN test.

Are there any risks to the test?

There is very little risk to having a blood test. You may have slight pain or bruising at the spot where the needle was put in, but most symptoms go away quickly.

What do the results mean?

If your results show you have a PTEN genetic mutation, it does not mean you have cancer, but your risk is higher than most people. But more frequent cancer screenings can reduce your risk. Cancer is more treatable when found in the early stages. If you have the mutation, your health care provider may recommend one or more of the following screening tests:

  • Colonoscopy, starting at age 35–40
  • Mammogram, starting at age 30 for women
  • Monthly breast self-exams for women
  • Yearly uterine screening for women
  • Yearly thyroid screening
  • Yearly check of skin for growths
  • Yearly kidney screening

Yearly thyroid and skin screenings are also recommended for children with a PTEN genetic mutation.

Is there anything else I need to know about a PTEN genetic test?

If you’ve been diagnosed with a PTEN genetic mutation or are thinking about getting tested, it may help to speak to a genetic counselor. A genetic counselor is a specially trained professional in genetics and genetic testing. If you haven’t yet been tested, the counselor can help you understand the risks and benefits of testing. If you have been tested, the counselor can help you understand the results and direct you to support services and other resources.

Tagged with:

About author

Related Articles